BlueNord ASA (BNOR)
Oslo Stock Exchange · Norway · prices in NOK · close of 22 Oct 2026
Key indicators
| Last close | NOK 617.00 |
|---|---|
| 52-week range | 399.50 – 629.00 |
| Return, 1 month / 3 months | +7.7% / +17.5% |
| Return, 1 year / 3 years | +123.2% / +99.7% |
| Trend | Uptrend |
| RSI (14) | 69 |
| Volatility (1 year) | 33.4% |
| Worst drawdown (1 year) | -15.8% |
| Average daily value traded | 80.49M NOK |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
BlueNord ASA is an independent oil and gas company based in Norway. It produces and sells crude oil and natural gas, mainly from fields in the Danish part of the North Sea, where it operates and holds interests in offshore licences. Its customers are buyers of oil and gas in European energy markets. The company also holds exploration and production interests in the region, and its activities centre on developing and maintaining its offshore fields.
BlueNord ASA trades under the code BNOR on the Oslo Stock Exchange in Norway, with its price quoted in Norwegian kroner (NOK). Our dividend records, which start in 2019, show payments in 2 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
BlueNord ASA (BNOR) trades on the Oslo Stock Exchange in Norway. It last closed at NOK 617.00 on 22 October 2026.
Its price-based Market X-Ray is 87 out of 100 (a strong price profile), ranking 1 of 294 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 123.2% and over the last three months it rose 17.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Oslo Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 96 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 34.4% | ||
| From 52-week high | 0.0% | ||
| Momentum | 91 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 17.5% | ||
| 6-month return | 48.8% | ||
| 12-month return, skipping the last month | 107.3% | ||
| Stability (higher is calmer) | 70 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 33.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -15.8% | ||
| Liquidity | 92 · Strong | Trades actively. | |
| Average daily value traded | 80.49M NOK | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 2 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +2.7% |
|---|---|
| 1 month | +7.7% |
| 3 months | +17.5% |
| 6 months | +48.8% |
| 1 year | +123.2% |
| 3 years | +99.7% |
| 5 years | +626.5% |
Signals
| 50-day / 200-day average | 574.10 / 459.14 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | Yes |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 12.90 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 17 Jul 2026 | NOK 66.8200 |
| 22 May 2026 | NOK 72.3400 |
| 24 Mar 2026 | NOK 42.8400 |
| 21 Nov 2025 | NOK 34.7500 |
| 28 Jul 2025 | NOK 19.4900 |
| 24 Jun 2025 | NOK 76.0500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Oslo Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.